会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 92. 发明申请
    • ALTERNATIVE SYNTHESIS OF RENIN INHIBITORS AND INTERMEDIATES THEREOF
    • 瑞宁抑制剂及其中间体的替代合成
    • US20070208055A1
    • 2007-09-06
    • US11573790
    • 2005-08-30
    • Gottfried SedelmeierStuart MickelHeinrich Rueeger
    • Gottfried SedelmeierStuart MickelHeinrich Rueeger
    • A61K31/45A61K31/165C07D263/60C07D211/40
    • C07D207/26C07C271/16C07C271/22C07D211/76C07D307/33
    • The present invention relates to synthetic routes to prepare a compound of the formula wherein R1 is halogen, C1-6halogenalkyl, C1-6alkoxy-C1-6alkyloxy or C1-6alkoxy-C1-6alkyl; R2 is halogen, C1-4alkyl or C1-4alkoxy; R3 and R4 are independently branched C3-6alkyl; and R5 is cycloalkyl, C1-6alkyl, C1-6hydroxyalkyl, C1-6alkoxy-C1-6alkyl, C1-4alkanoyloxy-C1-6alkyl, C1-6aminoalkyl, C1-6alkylamino-C1-6alkyl, C1-6dialkylamino-C1-6alkyl, C1-6alkanoylamino-C1-6alkyl, HO(O)C—C1-6alkyl, C1-6alkyl-O—(O)C—C1-6alkyl, H2N—C(O)—C1-6alkyl, C1-6alkyl-HN—C(O)—C1-6alkyl or (C1-6alkyl)2N—C(O)—C1-6alkyl; or a pharmaceutically acceptable salt thereof as well as key intermediates obtained when following these routes as well as their preparation.
    • 本发明涉及制备下式化合物的合成路线:其中R 1是卤素,C 1-6卤代烷基,C 1-6 烷氧基-C 1-6烷氧基或C 1-6烷氧基-C 1-6烷基; R 2是卤素,C 1-4烷基或C 1-4烷氧基; R 3和R 4分别独立地为支链C 3-6烷基; 和R 5是环烷基,C 1-6烷基,C 1-6 1-6羟基烷基,C 1-6烷基, 烷氧基-C 1-6烷基,C 1-4烷酰氧基-C 1-6烷基,C 1-6烷基, 亚氨基烷基,C 1-6烷基氨基-C 1-6烷基,C 1-6二烷基氨基-C 1-6 C 1 -C 6烷基,C 1-6烷酰基氨基-C 1-6烷基,HO(O)C 1-6亚烷基,C C 1 -C 6烷基-O-(O)C 1-6烷基,H 2 NC(O)-C 1 - C 1 -C 6烷基,C 1-6烷基-NH-C(O)-C 1-6烷基或(C 1-6)烷基, (O)-C 1-6烷基;(C 1 -C 6)烷基; 或其药学上可接受的盐以及按照这些途径获得的关键中间体及其制备方法。
    • 99. 发明申请
    • Novel anilide compounds and pharmaceutical compositions comprising them
    • 新型酰苯胺化合物和包含它们的药物组合物
    • US20020037910A1
    • 2002-03-28
    • US09789967
    • 2001-02-21
    • Kimiyuki ShibuyaKatsumi KawamineYukihiro SatoToshiyuki EdanoSouhei TanabeMasami Shiratsuchi
    • A61K031/428A61K031/423A61K031/4184C07D277/68C07D263/60C07D235/24
    • C07D263/58C07D235/28C07D277/70
    • The invention provides novel anilide compounds and pharmaceutical compositions comprising them. The invention relates to compounds of a formula: 1 wherein Ar is an optionally-substituted aryl group; R4 and R5 are the same or different, and each is a hydrogen atom, a lower alkyl group, or a lower alkoxy group; and R4 and R5 may together form a lower alkylene group of which one or more methylene moieties may optionally be substituted by oxygen and/or sulfur atoms; X is nullNHnull, or an oxygen or sulfur atom; Y is nullNHnull, an oxygen or sulfur atom, or a sulfoxide or sulfone group; Z is a single bond, or nullNR6null; R6 represents a hydrogen atom or a lower alkylene group; and n is an integer of from 0 to 15; and their salts and solvates. The compounds of the invention are useful as pharmaceutical compositions, especially as acyl coenzyme A cholesterol acyltransferase (ACAT) inhibitors.
    • 本发明提供了新的酰苯胺化合物和包含它们的药物组合物。 本发明涉及下式的化合物:其中Ar是任选取代的芳基; R4和R5相同或不同,各自为氢原子,低级烷基或低级烷氧基; 并且R 4和R 5可以一起形成其中一个或多个亚甲基部分可以任选被氧和/或硫原子取代的低级亚烷基; X是-NH-,或氧或硫原子; Y是-NH-,氧或硫原子,或亚砜或砜基; Z是单键,或-NR 6 - ; R6表示氢原子或低级亚烷基; n为0〜15的整数。 及其盐和溶剂合物。 本发明的化合物可用作药物组合物,特别是作为酰基辅酶A胆固醇酰基转移酶(ACAT)抑制剂。